SEKISUI DIAGNOSTICS, LLC: public contracts won without a rival in United States: 2 uncontested awards; 67% of its awards; 2 without a competition; 0 single bid.
Assay record ASY-US-0NH5XGL1LJ · Cite as: Assay Systems, “SEKISUI DIAGNOSTICS, LLC: public contracts won without a rival in United States”, https://assay-systems.com/register/us/uncontested/s/sekisui-diagnostics-llc/
SEKISUI DIAGNOSTICS, LLC won 2 of its 3 public contract awards in United States without a rival from 2023-11-08 to 2024-04-18, worth $-33: 2 without a competition and 0 after a competition that drew a single bid. 2 buyers awarded it without a rival, the largest Office of Assistant Secretary for Preparedness and Response with 1.
An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.
Office of Assistant Secretary for Preparedness and Response gave SEKISUI DIAGNOSTICS, LLC 1 award: 1 without a competition, 0 after a competition with a single bid. First 2023-11-08, latest 2023-11-08.
National Institutes of Health gave SEKISUI DIAGNOSTICS, LLC 1 award: 1 without a competition, 0 after a competition with a single bid. First 2024-04-18, latest 2024-04-18.
| Date | Buyer | How | Value | Stated reason |
|---|---|---|---|---|
| 2024-04-18 | National Institutes of Health 75N96019P00156 | No competition NOT COMPETED UNDER SAP | $-33 | AUTHORIZED BY STATUTE (FAR 6.302-5(A)(2)(I)) |
| 2023-11-08 | Office of Assistant Secretary for Preparedness and Response 75A50223C00048 | No competition NOT COMPETED | — | MOBILIZATION, ESSENTIAL R&D (FAR 6.302-3) |
Every uncontested award in United States · All countries
Source: USAspending.gov prime award transactions (contracts). Awards are matched to their buyer and supplier as published. Updated 17 October 2026.